The authorities announced a new antiviral program to combat pandemics.

The United States is investing $ 3.2 billion to develop pills for COVID-19 and other viruses that could trigger new pandemics.

As the leading US infectious diseases specialist Dr. Anthony Fauci told a White House briefing, the development of drugs will be part of a new initiative called the “Antiviral Program to Combat Pandemics.”

The program will support research to develop new drugs to address symptoms caused by the coronavirus and other potentially dangerous viruses.

COVID-19 tablets are already under development and could be available by the end of 2021 if clinical trials are successful. Earlier, the antiviral drug remdesivir was approved for the treatment of coronavirus in the United States.